344 related articles for article (PubMed ID: 1626537)
21. After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use.
Skidmore CA; Robertson JR; Robertson AA; Elton RA
BMJ; 1990 Jan; 300(6719):219-23. PubMed ID: 2106928
[TBL] [Abstract][Full Text] [Related]
22. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
23. Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach.
Rezza G; Nicolosi A; Zaccarelli M; Sagliocca L; Nespoli M; Gattari P; Spizzichino L; Ippolito G; Lazzarin A
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):500-3. PubMed ID: 8158545
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 and hepatitis B virus infections in adolescents lodged in security institutes of Buenos Aires.
Avila MM; Casanueva E; Piccardo C; Liberatore D; Cammarieri G; Cervellini M; Gojman I; Libonatti O
Pediatr AIDS HIV Infect; 1996 Oct; 7(5):346-9. PubMed ID: 11361493
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
[TBL] [Abstract][Full Text] [Related]
26. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
27. HIV infection in intravenous drug abusers in Berlin: risk factors and time trends.
Stark K; Müller R; Guggenmoos-Holzmann I; Deininger S; Meyer E; Bienzle U
Klin Wochenschr; 1990 Apr; 68(8):415-20. PubMed ID: 2348645
[TBL] [Abstract][Full Text] [Related]
28. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
29. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
30. HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC; Friedman SR
AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study.
Farci P; Novick DM; Orgiana G; Coiana A; Lai ME; Mandas A; Strazzera A; Marongiu F; Chessa L; Lusso P
Eur J Epidemiol; 1992 Jan; 8(1):132-5. PubMed ID: 1572423
[TBL] [Abstract][Full Text] [Related]
32. [HIV and AIDS in Poland in 2007].
Staszewska E; Laskus I; Rosińska M
Przegl Epidemiol; 2009; 63(2):271-7. PubMed ID: 19799260
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis and HIV infection in users of illegal drugs].
Scheitlin T; Joller-Jemelka HI; Grob PJ
Schweiz Med Wochenschr; 1992 Sep; 122(39):1432-45. PubMed ID: 1411402
[TBL] [Abstract][Full Text] [Related]
34. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study.
De Mercato R; Rezza G; Giuliani M; Perna E; Iovinella V; Bassi A; Tagliaferro R
Boll Ist Sieroter Milan; 1990 Jun; 69(2):447-8. PubMed ID: 2152304
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
Briggs NC; Battjes RJ; Cantor KP; Blattner WA; Yellin FM; Wilson S; Ritz AL; Weiss SH; Goedert JJ
J Infect Dis; 1995 Jul; 172(1):51-8. PubMed ID: 7797946
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
38. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme.
Steffen T; Blättler R; Gutzwiller F; Zwahlen M
Eur J Public Health; 2001 Dec; 11(4):425-30. PubMed ID: 11766485
[TBL] [Abstract][Full Text] [Related]
39. Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991.
Rezza G; De Rose A; Dorrucci M; Arpino C; Serafin I
Eur J Epidemiol; 1993 Nov; 9(6):663-6. PubMed ID: 8150071
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of human immunodeficiency virus infection in alcoholics.
de Oliveira LC; Pereira RG; Reis UC
Mem Inst Oswaldo Cruz; 2001 Jan; 96(1):21-3. PubMed ID: 11285472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
